Sabine Brookman-May, Senior Vice President and Therapeutic Area Head Urologic Oncology at Aura Biosciences, posted on X:
“Excellent Bladder Cancer session.
Important results on 2nd TURBT:
-
high residual tumor rates and upstaging rates.
-
important to do first TURBT right in the first place.
-
RWD like these are important to draw conclusions and improve outcomes.”
